Your browser is no longer supported. Please, upgrade your browser.
Settings
SGHT [NASD]
Sight Sciences, Inc.
Index- P/E- EPS (ttm)-1.28 Insider Own24.30% Shs Outstand39.85M Perf Week-9.74%
Market Cap946.48M Forward P/E- EPS next Y-1.52 Insider Trans4.67% Shs Float33.38M Perf Month-24.99%
Income-56.10M PEG- EPS next Q-0.37 Inst Own61.40% Short Float4.16% Perf Quarter-45.06%
Sales43.30M P/S21.86 EPS this Y-34.10% Inst Trans- Short Ratio5.54 Perf Half Y-
Book/sh6.17 P/B3.09 EPS next Y44.90% ROA- Target Price41.67 Perf Year-
Cash/sh5.48 P/C3.49 EPS next 5Y- ROE- 52W Range17.36 - 42.57 Perf YTD-43.01%
Dividend- P/FCF- EPS past 5Y- ROI56.80% 52W High-55.16% Beta-
Dividend %- Quick Ratio27.60 Sales past 5Y- Gross Margin79.10% 52W Low9.97% ATR1.80
Employees169 Current Ratio27.90 Sales Q/Q50.60% Oper. Margin- RSI (14)32.55 Volatility8.88% 8.17%
OptionableNo Debt/Eq0.13 EPS Q/Q-139.80% Profit Margin- Rel Volume0.51 Prev Close20.16
ShortableYes LT Debt/Eq0.13 EarningsNov 10 AMC Payout- Avg Volume250.36K Price19.09
Recom2.00 SMA20-18.39% SMA50-19.90% SMA200-34.26% Volume126,916 Change-5.31%
Nov-18-21 04:05PM  
Nov-17-21 08:00AM  
Nov-12-21 08:31AM  
Nov-11-21 08:03AM  
Nov-10-21 04:05PM  
04:04PM  
Nov-08-21 10:07AM  
Oct-27-21 04:05PM  
Oct-22-21 10:12AM  
05:56AM  
Oct-21-21 11:14AM  
07:56AM  
Oct-20-21 08:00AM  
Oct-15-21 11:09AM  
Sep-16-21 06:29PM  
Aug-26-21 04:05PM  
Aug-24-21 08:00AM  
Aug-12-21 04:05PM  
Aug-02-21 04:34PM  
Jul-22-21 08:14PM  
Jul-19-21 05:22PM  
Jul-14-21 06:53PM  
Sight Sciences, Inc., an ophthalmic medical device company, engages the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. The company's products include OMNI Surgical System, a therapeutic device used by ophthalmic surgeons to reduce intraocular pressure in adult glaucoma patients; and TearCare System, a wearable eyelid technology, for the treatment of dry eye disease (DED) for ophthalmologists and optometrists. It offers products through sales representatives and distributors to hospitals, medical centers, and eyecare professionals in the United States. The company was incorporated in 2010 and is headquartered in Menlo Park, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Selnick JesseChief Financial OfficerNov 23Buy18.4410,000184,3932,229,568Nov 23 08:05 PM
Encrantz StaffanDirectorOct 18Buy24.00527,04812,649,1523,497,118Oct 20 08:30 PM